Molecular Genetics of Dosage Compensation in Drosophila
Molecular Genetics of Dosage Compensation in Drosophila
批准号:
6401873
负责人:
Mitzi I Kuroda
金额:
$3.76万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2004-08-31
关键词:
Drosophilidae RNA arthropod genetics autosome binding sites chromatin chromosome translocation cooperative study crosslink dosage gene expression genetic mapping genetic transcription genome immunoprecipitation intermolecular interaction molecular genetics nucleoproteins sex chromosomes sex linked trait subtraction hybridization
中文摘要
描述(由申请人提供)
英文摘要
DESCRIPTION (provided by applicant)
This research will be done primarily in Russia as an extension of NIH grant #
R0l GM45744. Dosage compensation is a striking example of the interplay between
gene-specific regulation and chromosomal architecture. This process has evolved
to make X-linked gene expression equivalent in males with one X chromosome and
females with two. In species examined at the molecular level, dosage
compensation is mediated by sex-specific factors that decorate the X
chromosomes to regulate chromatin structure and gene expression. In Drosophila,
dosage compensation is achieved, at least in part, through site-specific
histone H4 acetylation, modulated by a male-specific, X-specific complex
(composed of the MSL proteins, and non-coding roX RNAs). Our focus in this
FIRCA proposal, enabled by the cytological expertise of the Zhimulev group,
will be to analyze the exquisite X chromosome-specificity of the Drosophila
dosage compensation complex.
We have recently proposed that in wild type males, the MSL complex forms at
approximately 30 chromatin entry sites, distributed exclusively along the X,
and is then attracted in cis to sequences or proteins that may be common to
active genes throughout the genome. This remarkable property of spreading in
cis will be examined by mapping the sites to which the complex spreads in the
endogenous X chromosome, as well as in cases where a transgene carrying a
chromatin entry site is inserted ectopically into an autosome. We will also
study conditions that affect the ability and site-specificity of MSL spreading,
including heat shock, limiting levels of the MSL2 subunit, and the behavior of
X:A translocation chromosomes.
In both flies and humans, regulatory molecules are normally restricted in cis
to the X chromosome, but if brought to autosomes, can spread on genes never
before dosage compensated. Dissecting the mechanisms underlying these
epigenetic regulatory processes will provide insight into many important
biological problems, including normal and disease states in humans. The superb
spatial resolution of polytene chromosomes, a defined initiation site for
spreading, and the availability of mutants in the protein and RNA spreading
components make the MSL complex an ideal model system to determine how changes
in chromatin architecture affect gene expression in complex organisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic regulation of transcriptional programming
-
批准号:10155516
-
项目类别:
-
资助金额:$71.76万
-
财政年份:2018
-
负责人:Mitzi I Kuroda
-
依托单位:
Epigenetic regulation of transcriptional programming
-
批准号:9922321
-
项目类别:
-
资助金额:$71.76万
-
财政年份:2018
-
负责人:Mitzi I Kuroda
-
依托单位:
Epigenetic regulation of transcriptional programming
-
批准号:10398124
-
项目类别:
-
资助金额:$71.76万
-
财政年份:2018
-
负责人:Mitzi I Kuroda
-
依托单位:
Comprehensive analysis of epigenetic regulators in their native chromatin context
-
批准号:8321675
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2012
-
负责人:Mitzi I Kuroda
-
依托单位:
Comprehensive analysis of epigenetic regulators in their native chromatin context
-
批准号:8598915
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2012
-
负责人:Mitzi I Kuroda
-
依托单位:
Comprehensive analysis of epigenetic regulators in their native chromatin context
-
批准号:9037141
-
项目类别:
-
资助金额:$36.92万
-
财政年份:2012
-
负责人:Mitzi I Kuroda
-
依托单位:
Comprehensive analysis of epigenetic regulators in their native chromatin context
-
批准号:8788710
-
项目类别:
-
资助金额:$33.74万
-
财政年份:2012
-
负责人:Mitzi I Kuroda
-
依托单位:
Comprehensive analysis of epigenetic regulators in their native chromatin context
-
批准号:8459396
-
项目类别:
-
资助金额:$32.56万
-
财政年份:2012
-
负责人:Mitzi I Kuroda
-
依托单位:
Molecular Genetics of Dosage Compensation in Drosophila
-
批准号:7901767
-
项目类别:
-
资助金额:$26.46万
-
财政年份:2009
-
负责人:Mitzi I Kuroda
-
依托单位:
Molecular Genetics of Dosage Compensation in Drosophila
-
批准号:6530113
-
项目类别:
-
资助金额:$4.1万
-
财政年份:2001
-
负责人:Mitzi I Kuroda
-
依托单位:
Molecular Genetics of Dosage Compensation in Drosophila
-
批准号:6834386
-
项目类别:
-
资助金额:$4.1万
-
财政年份:2001
-
负责人:Mitzi I Kuroda
-
依托单位:
MOLECULAR GENETICS OF DOSAGE COMPENSATION IN DROSOPHILA
-
批准号:2392138
-
项目类别:
-
资助金额:$9.56万
-
财政年份:1991
-
负责人:Mitzi I Kuroda
-
依托单位:
MOLECULAR GENETICS OF DOSAGE COMPENSATION IN DROSOPHILA
-
批准号:6386169
-
项目类别:
-
资助金额:$13.94万
-
财政年份:1991
-
负责人:Mitzi I Kuroda
-
依托单位:
MOLECULAR GENETICS OF DOSAGE COMPENSATION IN DROSOPHILA
-
批准号:6636025
-
项目类别:
-
资助金额:$13.94万
-
财政年份:1991
-
负责人:Mitzi I Kuroda
-
依托单位:
Molecular Genetics of Dosage Compensation in Drosophila
-
批准号:8052824
-
项目类别:
-
资助金额:$43.68万
-
财政年份:1991
-
负责人:Mitzi I Kuroda
-
依托单位:
Molecular Genetics of Dosage Compensation in Drosophila
-
批准号:8245208
-
项目类别:
-
资助金额:$43.74万
-
财政年份:1991
-
负责人:Mitzi I Kuroda
-
依托单位:
Molecular Genetics of Dosage Compensation in Drosophila
-
批准号:7784437
-
项目类别:
-
资助金额:$44.06万
-
财政年份:1991
-
负责人:Mitzi I Kuroda
-
依托单位:
MOLECULAR GENETICS OF DOSAGE COMPENSATION IN DROSOPHILA
-
批准号:2900748
-
项目类别:
-
资助金额:$13.33万
-
财政年份:1991
-
负责人:Mitzi I Kuroda
-
依托单位:
Molecular Genetics of Dosage Compensation in Drosophila
-
批准号:8448216
-
项目类别:
-
资助金额:$42.21万
-
财政年份:1991
-
负责人:Mitzi I Kuroda
-
依托单位:
MOLECULAR GENETICS OF DOSAGE COMPENSATION IN DROSOPHILA
-
批准号:2183361
-
项目类别:
-
资助金额:$8.03万
-
财政年份:1991
-
负责人:Mitzi I Kuroda
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RACK1乳酸化调控RNA损伤—核糖体应激通路介导卵巢癌铂耐药的分子机制和干预研究
-
批准号:82673836
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨毕康
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
24-脱氢胆固醇还原酶DHCR24作为RNA结合蛋白调控PIM1翻译促进肾透明细胞癌进展的功能机制研究
-
批准号:82606550
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2026
-
负责人:宁昊
-
依托单位:
糖基化RNA-lncRNA-GLY1通过激活ITGB1通路促进HBV相关肝癌转移的机制
-
批准号:2026JJ81914
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周克兵
-
依托单位:
X连锁RNA结合基序蛋白通过上调CXCL8分泌诱导巨噬细胞M2型极化促进结直肠癌奥沙利铂耐药
-
批准号:2026JJ80231
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曹婷
-
依托单位: